相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Lung Cancer and Interstitial Lung Diseases: A Systematic Review
Kostas Archontogeorgis et al.
PULMONARY MEDICINE (2012)
An Official ATS/ERSARS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management
Ganesh Raghu et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Smoking and Pulmonary Fibrosis: Novel Insights
Katerina D. Samara et al.
PULMONARY MEDICINE (2011)
Approval Summary: Erlotinib Maintenance Therapy of Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
Martin H. Cohen et al.
ONCOLOGIST (2010)
Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
Tony S. Mok et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
EGF receptor tyrosine kinase inhibitors diminish transforming growth factor-α-induced pulmonary fibrosis
William D. Hardie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2008)
Idiopathic pulmonary fibrosis - Outcome in relation to smoking status
Katerina M. Antoniou et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study
Shoji Kudoh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
A Phase I-II Study of Combined Blockade of the ErbB Receptor Network with Trastuzumab and Gefitinib in Patients with HER2 (ErbB2)-Overexpressing Metastatic Breast Cancer
Carlos L. Arteaga et al.
CLINICAL CANCER RESEARCH (2008)
Recurrent gefitinib-induced interstitial lung disease
Masaru Suzuki et al.
INTERNAL MEDICINE (2008)
Bevacizumab and Erlotinib: A Promising New Approach to the Treatment of Advanced NSCLC
Roy S. Herbst et al.
ONCOLOGIST (2008)
Idiopathic pulmonary fibrosis: Aberrant recapitulation of developmental programs?
Moises Selman et al.
PLOS MEDICINE (2008)
Gefitinib prevents bleomycin-induced lung fibrosis in mice
Yoshiki Ishii et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Predictive factors for interstitial lung disease, antitumor response, and survival in non-small-cell lung cancer patients treated with gefitinib
M Ando et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Epidermal growth factor receptor messenger RNA expression, gene dosage, and gefitinib sensitivity in non-small cell lung cancer
Rafal Dziadziuszko et al.
CLINICAL CANCER RESEARCH (2006)
Pulmonary toxicity from novel antineoplastic agents
I Dimopoulou et al.
ANNALS OF ONCOLOGY (2006)
Interstitial lung disease in lung cancer - Separating disease progression from treatment effects
S Danson et al.
DRUG SAFETY (2005)
EGFR mutations in lung cancer:: Correlation with clinical response to gefitinib therapy
JG Paez et al.
SCIENCE (2004)
Review of epidermal growth factor receptor biology
RS Herbst
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Severe acute interstitial pneumonia and gefitinib
A Inoue et al.
LANCET (2003)
The relationship of epidermal growth factor receptor levels to the prognosis of unresectable pharyngeal cancer patients treated by chemo-radiotherapy
N Magné et al.
EUROPEAN JOURNAL OF CANCER (2001)
Idiopathic pulmonary fibrosis: Prevailing and evolving hypotheses about its pathogenesis and implications for therapy
M Selman et al.
ANNALS OF INTERNAL MEDICINE (2001)
Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3
XM Chen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
分享论文
